Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Exosomes derived from dendritic cells].

S Amigorena1

  • 1Unité INSERM U520, Institut Curie, 12, rue Lhomond, 75005 Paris, France.

Journal De La Societe De Biologie
|September 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor development.

Oncogene·2010
Same author

Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Tumor-derived exosomes: a new source of tumor rejection antigens.

Vaccine·2002
Same author

FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.

Immunity·2002
Same author

Exosomes in cancer immunotherapy: preclinical data.

Advances in experimental medicine and biology·2002
Same journal

[Food safety of GMOs].

Journal de la Societe de biologie·2010
Same journal

[Placing on the market, breeders rights and growing genetically modified (GM) varieties].

Journal de la Societe de biologie·2010
Same journal

[Cultivation and environmental impacts of GMO crops].

Journal de la Societe de biologie·2010
Same journal

[Applications of genetically modified animals].

Journal de la Societe de biologie·2010
Same journal

[Why GMOs].

Journal de la Societe de biologie·2010
Same journal

[Mutations in renin-angiotensin system genes and kidney developmental anomalies].

Journal de la Societe de biologie·2010
See all related articles

Dendritic cell (DC)-derived exosomes can eliminate established tumors in mice by activating cytotoxic T lymphocytes. This suggests their potential as a novel cancer immunotherapy treatment.

Area of Science:

  • Immunology
  • Cell Biology
  • Nanotechnology

Background:

  • Dendritic cells (DCs) are crucial antigen-presenting cells that initiate cytotoxic immune responses.
  • DCs release exosomes, which are small membrane vesicles involved in intercellular communication.

Purpose of the Study:

  • To investigate the protein composition of DC-derived exosomes.
  • To evaluate the anti-tumor efficacy of DC-derived exosomes in vivo.

Main Methods:

  • Proteomic analysis of exosome protein content.
  • In vivo studies using mouse tumor models and exosome injections.
  • Analysis of immune cell populations (e.g., cytotoxic T lymphocytes) post-treatment.

Main Results:

Related Experiment Videos

  • Exosomes contain MHC, costimulatory, and adhesion molecules, as well as cytosolic factors.
  • A single injection of tumor peptide-sensitized DC-derived exosomes eradicated established mouse tumors.
  • Tumor-specific cytotoxic T lymphocytes were detected in treated mice, and CD8+ T cell depletion abrogated the anti-tumor effect.
  • Conclusions:

    • DC-derived exosomes possess potent anti-tumor properties mediated by CD8+ T cells.
    • These findings support the development of DC-derived exosomes for human cancer immunotherapy.